1.
Recombinant Factor Ⅷ for Treatment of Patients with Hemophilia A in China
重组人凝血因子Ⅷ在中国人血友病A患者中的安全性和有效性探讨
2.
Study on the Polymorphism of Intron 22 (CA)n Repeat within FⅧ Gene in Dai,Yi and Han Populations of Yunnan Province
凝血因子Ⅷ基因内二核苷酸重复序列在云南省傣、彝和汉族人群中的多态性研究
3.
Development of human coagulation factor Ⅷ,Ⅸ,Ⅺ in the healthy fetuses
胎儿期凝血因子Ⅷ、Ⅸ、Ⅺ的生成趋势
4.
Investigation on the mechanism of L-arginine improving human coagulant factor Ⅷ gene
L-精氨酸增强人凝血因子Ⅷ基因表达机制的研究
5.
The Correlation Analysis of Venous Thromboembolism with the Levels and Polymorphisms of Coagulation Factor Ⅷ
凝血因子Ⅷ与静脉血栓栓塞症相关性研究
6.
Study on Expression and Purification of Recombinant Human Coagulation Factor Ⅶ in Mammalian Cell Line;
重组人凝血因子Ⅶ的表达与纯化研究
7.
Gene Therapy for Hemophilia A Using Human Ribosomal DNA-targeting Vector Containing hFⅧ;
利用携带人凝血因子Ⅷ的核糖体基因区打靶载体进行血友病A基因治疗的研究
8.
Globulin Antihemophilia
抗血友病球蛋白[因子Ⅷ]
9.
Expression and Identification of Recombinant Human Coagulation Factor Ⅶa in Eukaryotic Cells;
重组人凝血因子Ⅶ在真核细胞中的表达研究
10.
Comparison of Modified Bethesda Assay and Nijmegen Assay in Detecting FⅧ Inhibitor in Patients with Hemophilia A
改进Bethesda方法和Nijmegen方法检测凝血因子Ⅷ抑制物的比较
11.
Detection of factor Ⅷ gene inversion in patients with severe hemophilia a carrier in Jiangxi provice by using long distance-PCR
用长距离PCR技术检测江西籍重型血友病甲Ⅷ因子基因倒位基因
12.
Experimental Research of Detecting the Plasma Fibrinogen and Coagulation Factor Ⅷ Using Piezoelectric Quartz Crystal Blood Coagulation Sensors;
压电石英晶体凝血传感器检测血浆纤维蛋白原和凝血因子Ⅷ的实验研究
13.
Hemorrhagic features and the application of recombinant activated factor VⅡ in liver transplantation
肝移植出血特点及活化重组人凝血因子VⅡ在移植中的应用(英文)
14.
Expression of Human Clotting Factor Ⅸ and Utero Gene Therapy Mediated by Recombinant Lentiviral Vector;
重组慢病毒载体介导的人凝血Ⅸ因子的表达及宫内基因治疗研究
15.
The correlation between the levels of plasma factor Ⅶ,Ⅷ and macroangiopathy in patients with type 2 diabetes
2型糖尿病患者血浆凝血因子Ⅶ、Ⅷ水平与大血管病变的相关性研究
16.
Safety of Factor Ⅸ Gene Transfer to Colon Cell in Murine Hemophilia B by Recombinant Adeno-associated Viral Vector
结肠灌注重组腺相关病毒2/人凝血因子Ⅸ基因载体治疗血友病B的安全性研究
17.
At 1 and 2 weeks after endothelium denudation,Ⅷ factor immunohistochemical staining and Evans blue staining were used to measure the reendothelialized area.
术后1周、2周分别应用Ⅷ因子检测和伊文思蓝染色评价各组损伤血管内皮修复情况;
18.
Obtaining of human platelet factor 4 by means of genetic engineering technique
基因工程技术获取重组人血小板因子4